ES2054171T3 - RADIOACTIVE DIAGNOSTIC AGENT. - Google Patents

RADIOACTIVE DIAGNOSTIC AGENT.

Info

Publication number
ES2054171T3
ES2054171T3 ES90113475T ES90113475T ES2054171T3 ES 2054171 T3 ES2054171 T3 ES 2054171T3 ES 90113475 T ES90113475 T ES 90113475T ES 90113475 T ES90113475 T ES 90113475T ES 2054171 T3 ES2054171 T3 ES 2054171T3
Authority
ES
Spain
Prior art keywords
diagnostic agent
radioactive diagnostic
radioactive
atomy
understands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90113475T
Other languages
Spanish (es)
Inventor
Akira Yokoyama
Yasuhiro Magata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Medi Physics Co Ltd
Original Assignee
Nihon Medi Physics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Medi Physics Co Ltd filed Critical Nihon Medi Physics Co Ltd
Application granted granted Critical
Publication of ES2054171T3 publication Critical patent/ES2054171T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)

Abstract

UN AGENTE DE DIAGNOSTICO RADIOACTIVO EL CUAL COMPRENDE COMO INGREDIENTE ACTIVO UN DERIVADO DE GLUCOSAMINA DE FORMULA: EN DONDE AC ES UN GRUPO ACETILO Y X ES UN ATOMO DE YODO RADIOACTIVO.A RADIOACTIVE DIAGNOSTIC AGENT WHICH UNDERSTANDS AS AN ACTIVE INGREDIENT A GLUCOSAMINE DERIVATIVE OF FORMULA: WHERE AC IS AN ACETYL GROUP AND X IS AN ATOMY OF RADIOACTIVE IODINE.

ES90113475T 1989-07-13 1990-07-13 RADIOACTIVE DIAGNOSTIC AGENT. Expired - Lifetime ES2054171T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1181502A JP2690018B2 (en) 1989-07-13 1989-07-13 Radioactive diagnostic agent consisting of glucosamine derivative

Publications (1)

Publication Number Publication Date
ES2054171T3 true ES2054171T3 (en) 1994-08-01

Family

ID=16101881

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90113475T Expired - Lifetime ES2054171T3 (en) 1989-07-13 1990-07-13 RADIOACTIVE DIAGNOSTIC AGENT.

Country Status (9)

Country Link
US (1) US5034212A (en)
EP (1) EP0413145B1 (en)
JP (1) JP2690018B2 (en)
AT (1) ATE86122T1 (en)
AU (1) AU626702B2 (en)
CA (1) CA2021173C (en)
DE (1) DE69001000T2 (en)
DK (1) DK0413145T3 (en)
ES (1) ES2054171T3 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU698176B2 (en) * 1993-07-28 1998-10-29 Cis Bio International Radiolabelled glucans
JP3645580B2 (en) * 1993-10-22 2005-05-11 株式会社フジモト・ブラザーズ Brain metabolism improving agent containing glucose ester derivative
ES2190797T3 (en) * 1996-03-28 2003-08-16 Nihon Mediphysics Co Ltd DIAGNOSTIC AGENT FOR GLYCOMETABOLIC FUNCTION.
AU9807398A (en) * 1997-10-20 1999-05-10 Board Of Regents, The University Of Texas System Single photon-emitting radiotraces and methods for their use
AU2002360766A1 (en) 2001-12-21 2003-07-30 Threshold Pharmaceuticals, Inc. Methods for cancer imaging
CN106565797B (en) * 2016-10-18 2019-06-14 浙江工业大学 Glucose amide compound and preparation and application thereof

Also Published As

Publication number Publication date
AU626702B2 (en) 1992-08-06
AU5902090A (en) 1991-01-17
US5034212A (en) 1991-07-23
ATE86122T1 (en) 1993-03-15
CA2021173C (en) 1999-12-28
DE69001000D1 (en) 1993-04-08
JP2690018B2 (en) 1997-12-10
DK0413145T3 (en) 1993-04-05
DE69001000T2 (en) 1993-06-09
EP0413145B1 (en) 1993-03-03
CA2021173A1 (en) 1991-01-14
JPH0347137A (en) 1991-02-28
EP0413145A1 (en) 1991-02-20

Similar Documents

Publication Publication Date Title
PT650476E (en) PERIPHERAL VASODILATING AGENT CONTAINING N-ACILLATED 4-AMINO-PIPERIDINE DERIVATIVES AS ACTIVE INGREDIENTS
ES2187575T3 (en) CYCLE HEXAPEPTIDES GIVEN WITH ANTIBIOTIC ACTIVITY.
PE2896A1 (en) DERIVED FROM ERYTHROMYCIN, ITS PREPARATION PROCEDURE AND ITS APPLICATION AS A MEDICINAL PRODUCT
MX9202407A (en) PHARMACEUTICAL COMPOSITION CONTAINING AN ALYLAMINE COMPOUND AS THE ACTIVE AGENT AND PROCESS FOR ITS PREPARATION.
FR2406641A1 (en) 2,6-DIAMINONEBULARINS AND THEIR THERAPEUTIC APPLICATION
ES2044912T3 (en) PHARMACEUTICAL COMPOSITIONS EQUIPPED WITH SEQUESTRATING ACTIVITY FOR BILIARY ACIDS, CONTAINING CHOLESTIRAMINE AS AN ACTIVE SUBSTANCE, AND PROCEDURE FOR ITS PREPARATION.
ES2095884T3 (en) ANTIVIRAL AGENT.
ES2134801T3 (en) CRYSTAL TIAGABINE HYDROCHLORIDE MONOHYDRATE, ITS PREPARATION AND USE.
ES2054171T3 (en) RADIOACTIVE DIAGNOSTIC AGENT.
DK403187A (en) TRANSDERMAL TAX PREPARATION
AR223808A1 (en) HERBICIDE COMPOSITIONS CONTAINING M-PHENOXYBENZAMIDE DERIVATIVES AS AN ACTIVE AGENT
FR2363330A1 (en) MEDICINE INTENDED TO REDUCE FERTILITY IN MAMMALS
GB1097566A (en) Anthelmintic agents
ES2055867T3 (en) DIBENZOTIAZEPINE DERIVATIVES USEFUL AS ANTIESPASMODIC AGENTS.
ES2144154T3 (en) DERIVATIVES OF ERYTHROMYCIN A 9-0-OXIME GIVEN WITH ANTIBIOTIC ACTIVITY.
SE8303700L (en) THERAPEUTIC COMPOSITION
ES2127263T3 (en) NEW TRIEN-CHROMENIC DERIVATIVES, THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
AR219697A1 (en) RODENTICIZED COMPOSITION COMPRISING A COMPOUND OF DIPHENYLAMINE AS AN ACTIVE INGREDIENT
ES2039719T3 (en) PROCEDURE TO PREPARE A THERAPEUTIC AGENT FOR THE TREATMENT OF ULCERA PEPTICA DISEASE.
ES2032797T3 (en) THERAPEUTIC AGENT FOR THE TREATMENT OF ULCERA PEPTICA DISEASE.
ES2072332T3 (en) DERIVATIVES OF DIBENZO (1,5) DIOXOCIN-5-ONA, ITS USE IN MEDICINES AND THE PROCEDURE FOR ITS MANUFACTURE.
ES2040240T3 (en) PLATINUM CYSTOSTATIC AGENT.
ES2169124T3 (en) ACID 4-AMINOMICOPENOLICO 6-REPLACED AND DERIVATIVES WITH IMMUNOSUPPRESSING ACTIVITY.
ES2054186T3 (en) ANTIHEPATOPATHIC COMPOSITION.
ES2151572T3 (en) BENZOILGUANIDINAS REPLACED WITH TRIFLUOROPROPILO AND ITS EMPLOYMENT AS A MEDICINAL OR DIAGNOSTIC AGENT.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 413145

Country of ref document: ES